A meta-analysis of anti-inflammatory agents for the treatment of pediatric OSA found that montelukast plus intranasal steroids or montelukast alone may benefit patients with mild OSA.
Nocturnal hypoxemia, along with COPD, increased the risk for cardiovascular events and mortality in female patients with suspected obstructive sleep apnea.
Preoperative apnea hypopnea index in patients with OSA correlated with postoperative adverse events.
For individuals with obstructive sleep apnea, those with short respiratory event duration have an increased risk for mortality.
Electrical stimulation of the hypoglossal nerve could be a viable treatment alternative to continuous positive airway pressure in obstructive sleep apnea.
The SAVE study was a multicenter, international clinical trial that tested the efficacy of continuous positive airway pressure and normal care in patients with sleep apnea.
Obese pediatric patients with obstructive sleep apnea were more likely to have abnormal metabolic profiles, including high triglyceride and alanine transaminase levels, compared with obese children without obstructive sleep apnea.
Continuous positive airway pressure for obstructive sleep apnea in patients with type 2 diabetes offered no improvement in visual acuity compared with usual care alone.
Sleep-disordered breathing severity has been independently associated with increased aggressiveness of cutaneous melanoma.
Obese patients with obstructive sleep apnea have a significantly narrower upper airway, specifically of the retropalatal region, compared with obese individuals without obstructive sleep apnea.
